Development and characterisation of chitosan nanoparticles for siRNA delivery

被引:538
作者
Katas, Haliza [1 ]
Alpar, H. Oya [1 ]
机构
[1] Univ London, Sch Pharm, London WC1N 1AX, England
关键词
siRNA; chitosan; delivery system; simple complexation; ionic gelation;
D O I
10.1016/j.jconrel.2006.07.021
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Gene silencing mediated by double-stranded small interfering RNA (siRNA) has been widely investigated as a potential therapeutic approach for diseases with genetic defects. The use of siRNA, however, is hampered by its rapid degradation and poor cellular uptake into cells in vitro or in vivo. Therefore, we have explored chitosan as a siRNA vector due to its advantages such as low toxicity, biodegradability and biocompatibility. Chitosan nanoparticles were prepared by two methods of ionic cross-linking, simple complexation and ionic gelation using sodium tripolyphosphate (TPP). Both methods produced nanosize particles, less than 500 nm depending on type, molecular weight as well as concentration of chitosan. In the case of ionic gelation, two further factors, namely chitosan to TPP weight ratio and pH, affected the particle size. In vitro studies in two types of cells lines, CHO K1 and HEK 293, have revealed that preparation method of siRNA association to the chitosan plays an important role on the silencing effect. Chitosan-TPP nanoparticles with entrapped siRNA are shown to be better vectors as siRNA delivery vehicles compared to chitosan-siRNA complexes possibly due to their high binding capacity and loading efficiency. Therefore, chitosan-TPP nanoparticles show much potential as viable vector candidates for safer and cost-effective siRNA delivery. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:216 / 225
页数:10
相关论文
共 33 条
[1]   Gene silencing nucleic acids designed by scanning arrays: Anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridization-accessible region using the same delivery system [J].
Beale, G ;
Hollins, AJ ;
Benboubetra, M ;
Sohail, M ;
Fox, SP ;
Benter, I ;
Akhtar, S .
JOURNAL OF DRUG TARGETING, 2003, 11 (07) :449-456
[2]   PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium [J].
Bivas-Benita, M ;
Romeijn, S ;
Junginger, HE ;
Borchard, G .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (01) :1-6
[3]   LIGHT-SCATTERING-STUDIES ON DNA CONDENSATION [J].
BLOOMFIELD, VA ;
HE, SQ ;
LI, AZ ;
ARSCOTT, PB .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1991, 19 (02) :496-496
[4]   CONDENSATION OF DNA BY MULTIVALENT CATIONS - CONSIDERATIONS ON MECHANISM [J].
BLOOMFIELD, VA .
BIOPOLYMERS, 1991, 31 (13) :1471-1481
[5]   DNA condensation [J].
Bloomfield, VA .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1996, 6 (03) :334-341
[6]   RNA interference in mammalian cells by chemically-modified RNA [J].
Braasch, DA ;
Jensen, S ;
Liu, YH ;
Kaur, K ;
Arar, K ;
White, MA ;
Corey, DR .
BIOCHEMISTRY, 2003, 42 (26) :7967-7975
[7]  
CALVO P, 1998, P WORLD M APGI APV, V2, P1111
[8]  
CHAN V, 2001, EFFECT CHITOSAN MOL
[9]   Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery [J].
Gan, Q ;
Wang, T ;
Cochrane, C ;
McCarron, P .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2005, 44 (2-3) :65-73
[10]   Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector [J].
Gao, SY ;
Chen, JN ;
Dong, L ;
Ding, Z ;
Yang, YH ;
Zhang, JF .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 60 (03) :327-334